The Home of the Life Sciences Industry

Explore Latest News

Takeda Pharma and Shire Come Back to the Negotiating Table

Takeda Pharmaceutical has come back with an improved bid for Shire, making it the fifth round of talks.

Biogen’s First Quarter Driven by MS Drugs and Spinraza

Biogen saw a strong first quarter with 11 percent growth in revenues to $3.1 billion, which were spurred by gains in spinal muscular atrophy (SMA) treatment Spinraza and multiple sclerosis treatment Tecfidera.


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.